Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06647589 · ClinicalTrials.gov registry record · NA
Acceptance and Commitment Therapy for Religious OCD
A NA study of Obsessive Compulsive Disorder (OCD), sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06647589: Recruiting NA study of Obsessive Compulsive Disorder (OCD), sponsored by University of Alabama at Birmingham.
NCT06647589 is a NA study of Obsessive Compulsive Disorder (OCD) that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 10 participants, below the 243-participant average among 12 other Obsessive Compulsive Disorder (OCD) trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06647589, a NA study of Obsessive Compulsive Disorder (OCD), is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to examine the effects and feasibility of a specific form of psychotherapy, acceptance and commitment therapy (ACT), on religiously oriented obsessive and compulsive disorder (OCD).
Primary Outcome
The Scrupulosity Obsessions and Compulsions Scale (SOCS) is a 10-item scale that asks participants how often they experience religious OCD obsessions and compulsions. The questions are asked on a scale ranging from 0 (Very Rarely) to 5 (Very Often).
Conditions Studied
Interventions
- BEHAVIORAL Acceptance and Commitment Therapy
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-07-30 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT06647589 shows while recruiting
NCT06647589 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 243-participant average among 12 other Obsessive Compulsive Disorder (OCD) trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Obsessive Compulsive Disorder (OCD) appearing as the primary indexed condition, and to 1 intervention - of which Acceptance and Commitment Therapy is the first listed.
NCT06647589 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06647589 about?
NCT06647589 is a clinical study titled "Acceptance and Commitment Therapy for Religious OCD". The purpose of the study is to examine the effects and feasibility of a specific form of psychotherapy, acceptance and commitment therapy (ACT), on religiously oriented obsessive and compulsive disorder (OCD).
What is the current status of trial NCT06647589?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-07-30. Estimated completion is 2026-09-01.
What conditions does trial NCT06647589 study?
This clinical trial studies the following conditions: Obsessive Compulsive Disorder (OCD).
What interventions are being tested in trial NCT06647589?
The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06647589?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06647589 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive Compulsive Disorder (OCD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06647589's enrollment target sits among peer trials
10 11th of 12 higher than 1 of 12 other Obsessive Compulsive Disorder (OCD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive Compulsive Disorder (OCD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder
RECRUITING · NA
-
ERP to Improve Functioning in Veterans With OCD
RECRUITING · NA
-
Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder
RECRUITING · NA
-
Stepped Care Treatment for Anxiety Resilience
RECRUITING · NA
-
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
RECRUITING · NA
-
Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI